GRETCHEN WILSON: Open Payments
NPI 1073574232 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,875 in 60 payments from 8 companies in 2025. Trend: 2023 $6,419 · 2024 $1,821 · 2025 $3,875
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 37 | $2,460 |
| AtriCure, Inc. | 12 | $594 |
| Abbott Laboratories | 4 | $398 |
| Getinge USA Sales, LLC | 2 | $200 |
| AstraZeneca Pharmaceuticals LP | 2 | $143 |
| Corcym Inc | 1 | $32 |
| La Jolla Pharmaceutical Company | 1 | $30 |
| Chiesi USA, Inc. | 1 | $17 |
Products named: NAVITOR, VASOVIEW HEMOPRO 2, AtriCure cryoICE Cryoablation System (CRYO2), EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, FARXIGA, ATRICLIP LAA EXCLUSION SYSTEM, OPTIS.
Industry payments across TX — which companies pay providers there.
